Here we documented for the first time that kidney-derived c-kit+ progenitor/stem cell and MSC treatment targeted the actin cytoskeleton in podocytes and both accelerated the reversal of foot process effacement (FPE) after PAN injection, representing an important therapeutic approach for glomerular disease. The gene discussed is KIT; the disease is glomerular disorder.